Trials / Completed
CompletedNCT02655380
Remifentanil Requirement for Acceptable Intubating Condition
Remifentanil Requirement for Acceptable Intubating Condition With Two Dose Ketamine Without Neuromuscular Blocking Agent in Children
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 51 (actual)
- Sponsor
- Ajou University School of Medicine · Academic / Other
- Sex
- All
- Age
- 3 Years – 12 Years
- Healthy volunteers
- Not accepted
Summary
Ketamine and opioid are known to improve the intubating condition, respectively. Combination of ketamine and opioid potentiate analgesic effect and give hemodynamic stability in complementary manner. Therefore, the combination use of ketamine and remifentanil could be useful for acceptable intubating condition in the general anesthesia without the use of neuromuscular blocking agent. Generally, induction dose of ketamine ranges between 1 and 2 mg. There was no report about the optimal dose of remifentanil with 1 or 2 mg ketamine induction dose for intubation without neuromuscular blocking agent. The investigators focus on remifentanil dose using Dixon's up and down method.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ketamine 1 | Anesthesia induction is performed with 1 mg ketamine. |
| DRUG | Ketamine 2 | Anesthesia induction is performed with 2 mg ketamine. |
| DRUG | Remifentanil | After anesthesia induction with ketamine, predetermined remifentanil using Dixon's up and dowm method is administered. |
Timeline
- Start date
- 2017-06-19
- Primary completion
- 2018-04-16
- Completion
- 2018-04-16
- First posted
- 2016-01-14
- Last updated
- 2019-01-10
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT02655380. Inclusion in this directory is not an endorsement.